Early detection prog for endometrial, ovarian cancer in women launched | Mysuru News

Spread the love


Early detection prog for endometrial, ovarian cancer in women launched

Mysuru: Surgery is the primary treatment for two of the most prevalent gynaecological cancers, Apollo BGS Hospitals surgical oncologist Dr Y Ramya said on Wednesday. She highlighted that advances in minimally invasive surgery and cytoreductive surgery have helped patients to have a faster and better recovery.Speaking to reporters during the launch of Apollo Cancer Centre’s End-O Check, a comprehensive early detection programme targeting women aged 45 and above, she stated that the initiative is designed to detect endometrial and ovarian cancer at an early and more treatable stage.Ovarian cancer is a silent killer as the majority of women come to the hospital only in the advanced stage due to non-specific early symptoms. “Endometrial cancers can be picked up very early due to early presentation. Still, patients approach us in late stages due to negligence or lack of awareness. Both cancers are curable if detected and treated in the early stages,” Ramya said.Dr Vanitha LV, senior consultant–obstetrics & gynaecology at Apollo BGS Hospitals, said, “Endometrial cancer has been on the rise in women above the age of 45 years, so early detection is crucial for better outcomes. Global data indicates a five-year survival rate of around 96% for localised disease. Key risk factors include obesity, diabetes, early menstruation, and late menopause, all of which are becoming more prevalent among Indian women.Dr Naveen Jayaram, consultant medical oncologist, said, “Ovarian cancer is the third most common cancer in India, with a younger median age of diagnosis (50–56 years) compared to the West (around 63 years). Over 70% of Indian women are diagnosed at an advanced stage due to vague early symptoms and lack of effective screening. Common symptoms include abdominal pain, bloating, and gastrointestinal issues. Advanced-stage survival averages 20-30 months, while early-stage survival can exceed 80%.Dr Ranjitha V N, consultant oncopathologist, was present.





Source link

Leave a Reply

Your email address will not be published. Required fields are marked *